Avalo Therapeutics, Inc. · NASDAQ:AVTX
Ikarian Capital, LLC reported a 9.99% stake in Avalo Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Ikarian Capital, LLC reported a 9.99% stake in Avalo Therapeutics, Inc., 1,191,957 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 1,191,957
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ikarian Capital, LLC | 9.99% | 1,191,957 |
| Neil Shahrestani | 9.99% | 1,191,957 |
Source
Related
- Avalo Therapeutics, Inc.
- Ikarian Capital, LLC
- Avalo Therapeutics, Inc. shareholders
- Schedule 13G/A · Ikarian Capital, LLC · Nov 14, 2025
- Form 4 · Sullivan Christopher Ryan · Sep 18, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 11, 2026
- Form 4 · Doyle Mittie · Sep 1, 2026
- Form 4 · Sullivan Christopher Ryan · Aug 19, 2026
- Form 4 · Doyle Mittie · Aug 19, 2026